Glycan adjuvantation expands the breadth and duration of protection of a mRNA-based vaccine
RNA-seq (gene expression) · mouse · 30 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 30 samples: 30 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccinesNature immunology · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE255778_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1076511. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 30 sample titles: 30 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8079903 A1_Comirnaty_Day-1 (Rep-1)
- GSM8079904 A2_Comirnaty_Day-1 (Rep-2)
- GSM8079905 A3_Comirnaty_Day-1 (Rep-3)
- GSM8079906 A4_Comirnaty+MA_Day-1 (Rep-1)
- GSM8079907 A5_Comirnaty+MA_Day-1 (Rep-2)
- GSM8079908 A6_Comirnaty+MA_Day-1 (Rep-3)
- GSM8079909 A7_Comirnaty+Alum_Day-1 (Rep-1)
- GSM8079910 A8_Comirnaty+Alum_Day-1 (Rep-2)
- GSM8079911 A9_Comirnaty+Alum_Day-1 (Rep-3)
- GSM8079912 B10_Comirnaty_Day-3 (Rep-1)
- GSM8079913 B11_Comirnaty_Day-3 (Rep-2)
- GSM8079914 B12_Comirnaty_Day-3 (Rep-3)
- GSM8079915 B13_Comirnaty+MA_Day-3 (Rep-1)
- GSM8079916 B14_Comirnaty+MA_Day-3 (Rep-2)
- GSM8079917 B15_Comirnaty+MA_Day-3 (Rep-3)
- GSM8079918 B16_Comirnaty+Alum_Day-3 (Rep-1)
- GSM8079919 B17_Comirnaty+Alum_Day-3 (Rep-2)
- GSM8079920 B18_Comirnaty+Alum_Day-3 (Rep-3)
- GSM8079921 C19_Comirnaty_Day-7 (Rep-1)
- GSM8079922 C20_Comirnaty_Day-7 (Rep-2)
- GSM8079923 C21_Comirnaty_Day-7 (Rep-3)
- GSM8079924 C22_Comirnaty+MA_Day-7 (Rep-1)
- GSM8079925 C23_Comirnaty+MA_Day-7 (Rep-2)
- GSM8079926 C24_Comirnaty+MA_Day-7 (Rep-3)
- GSM8079927 C25_Comirnaty+Alum_Day-7 (Rep-1)
- GSM8079928 C26_Comirnaty+Alum_Day-7 (Rep-2)
- GSM8079929 C27_Comirnaty+Alum_Day-7 (Rep-3)
- GSM8079930 NT28_Control (Rep-1)
- GSM8079931 NT29_Control (Rep-2)
- GSM8079932 NT30_Control (Rep-3)
- GSE315320 A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines. 12 samples shares protection, mrna-based, duration, expands, breadth, vaccine, glycan
- GSE322599 An mRNA vaccine confers enhanced protection against herpes sim-plex virus through a type I interferon-dependent pathway 12 samples shares protection, vaccine
- GSE261311 Vaccine based on immune evasion mutations integrated RBD protein have broad protection against SARS-CoV-2 [mRNA-seq] 12 samples shares protection, vaccine
- GSE271485 Innate cells and STAT1-dependent signals orchestrate vaccine-induced protection against invasive Cryptococcus infection 10 samples shares protection, vaccine
- GSE281662 A new mRNA antigen vaccine induces potent B and T cell responses and in vivo protection against SARS-CoV-2 9 samples shares protection, vaccine
- GSE282488 Heterologous immunization combining vector- and mRNA-based vaccine elicits both robust innate and adaptive immune responses 3 samples shares mrna-based, vaccine
- GSE276667 A multivalent mRNA vaccine elicits robust immune responses and confers protection in a murine model of monkeypox virus infection 18 samples shares protection, vaccine
- GSE278523 Systems biology mapping of rBCG-LTAK63-induced protection against tuberculosis reveals the significance of autophagy and circadian rhythm regulation by cAMP 126 samples shares protection
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.